logo
  

Tyco Board Approves Addl. $1 Bln Authorization For Share Buybacks - Quick Facts

Swiss security products maker Tyco International Ltd.'s (TYC) shareholders approved each proposal presented at the special general meeting of shareholders held on September 9, 2014. Therefore, the firm expects to complete the merger between Tyco International Ltd. and its subsidiary, Tyco International plc, in November 2014. The merger would result in each shareholder of Tyco International Ltd. receiving one share of Tyco International plc, a company incorporated under the laws of Ireland, for each share of Tyco International Ltd. held immediately prior to the merger.

In addition, Tyco's Board approved an additional $1 billion authorization for share repurchases, as the current authorized program is likely to be completed in the first fiscal quarter of 2015.

Further, the board declared a quarterly dividend of $0.18 per share, payable on November 13, 2014, to shareholders of record at the close of trading on the New York Stock Exchange on October 24, 2014.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and...

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT